Study Shows Hydroxychloroquine Does Not Prevent COVID-19
Click the image below to enlarge the infographic.
- Hydroxychloroquine was no better than placebo in preventing COVID-19 symptoms in people who are exposed to the coronavirus, a new study from the University of Minnesota Medical School finds
- The study involved 821 participants who had close contact with a confirmed COVID-19 patient
- The participants were sent doses of either hydroxychloroquine or placebo, which they took for two weeks. Being a randomized trial, neither the study particpants nor the researchers knew who was taking placebo or hydroxychloroquine
- After the two weeks of evaluation, there was no difference in the rate of development of the disease between those who took placebo ansd those who took hydroxychloroquine
- About 12 percent of participants who took hydroxychloroquine developed COVID-19 symptoms, compared with 14 percent of those who received placebo
- The study is the first major trial examining the efficacy of hydroxychlorquine as a prophylactic drug against COVID-19